• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Americas Cancer Biologic Therapy Market

    ID: MRFR/Pharma/0148-HCR
    45 Pages
    Rahul Gotadki
    October 2025

    Americas Cancer Biological Therapy market information, by type (Monoclonal Antibodies,  Gene Therapy, Colony-Stimulating Factors, Targeted Therapy and Others) by end users (hospitals & clinics, cancer research centers, laboratories) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Americas Cancer Biologic Therapy Market Infographic
    Purchase Options

    Americas Cancer Biologic Therapy Market Summary

    The United States Americas Cancer Biological Therapy market is projected to grow from 98.4 USD Billion in 2024 to 133.4 USD Billion by 2035.

    Key Market Trends & Highlights

    Americas Cancer Biological Therapy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 2.8 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 133.4 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 98.4 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of biological therapies due to increasing cancer prevalence is a major market driver.

    Market Size & Forecast

    2024 Market Size 98.4 (USD Billion)
    2035 Market Size 133.4 (USD Billion)
    CAGR (2025-2035) 2.8%

    Major Players

    Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation

    Key Companies in the Americas Cancer Biologic Therapy Market market include

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 90.2 (USD Billion)
    Market Size 2024 98.4 (USD Billion)
    Market Size 2032 104.7 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.4 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered US, Canada, and Rest of America
      Key Vendors Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others
    Key Market Opportunities Technological advances and funding available for the development of new therapeutics and treatment
    Key Market Drivers Increasing number of patients, limited option of therapy, patent expiry of cancer drug

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials